secwatch.observer — SEC 8-K summary
======================================

Issuer:     RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK:        0001649904
Form:       8-K
Filed at:   2024-09-19T23:59:59+00:00
Accession:  0001104659-24-101393
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Rhythm Pharma shareholders elect three directors, approve equity plan at annual meeting
--------------------------------------------------------------------------------

- Elected Class I directors: Stuart Arbuckle (45.6M for), Christophe Jean (45.0M), Lynn Tetrault (45.5M).
- Ratified Ernst & Young as auditor: 53.8M for, 69.5K against.
- Advisory vote on executive compensation: 50.6M for, 1.5M against.
- Reapproved 2017 Equity Incentive Plan: 32.7M for, 19.4M against (63% of votes cast).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649904/000110465924101393/0001104659-24-101393-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649904/000110465924101393/tm2424430d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-101393

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer